News

At the virtual World Vaccine Congress Washington 2021, scientists and pediatricians discussed the pros and cons of vaccinating children and adolescents against COVID-19.

A look at the highlights from the 30th annual Pediatric Pharmacy Association meeting.

The US Food & Drug Administration is about to authorize use of the Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15 years old.

Adverse childhood experiences (ACEs) are associated with poor health outcomes over the course of a life, but there is still little information on clinical workflows to guide these implementation practices. At the virtual 2021 virtual Pediatric Academic Societies meeting, Julia I. Reading discussed models and variations in ACE screening workflows.

The Bronx experienced 1 of the highest mortality rates of COVID-19 during the beginning of the pandemic. Some early research suggests that quarantine and school closures had a major psychosocial impact on children during this time. A study presented at the virtual 2021 Pediatric Academic Societies meeting looks at how children and teenagers living in low socioeconomic settings were affected by the pandemic.

Breast milk is best, but for those babies who won’t or don’t breastfeed there are formula alternatives. Here’s a primer on infant formulas and how to decide which option is appropriate for the individual child.

The FDA announces 2 standards to reduce disease and death from tobacco products.

The American Academy of Pediatrics states that children accounted for almost 20% of new cases of COVID-19 during the week ending March 25, with more than 64,000 new cases reported.

Emerging evidence reveals that earlier introduction of highly allergenic foods into infants’ diets may actually lead to immune tolerance. Here’s what you should know.

The FDA approves Xeomin (incobotulinumtoxinA) for chronic sialorrhea in children.

The latest advances in medical technology for the pediatrician's office.

It was a very busy week for the Contemporary Pediatrics team.

Contemporary Pediatrics sat down with Andrew J. Schuman, MD, FAAP, who is a clinical assistant professor of pediatrics at the Geisel School of Medicine at Dartmouth and also a practicing pediatrician, to talk about why he went into medicine and what he loves about pediatrics.

The impact of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act continues to benefit children’s health.

Sudden unexplained death in childhood (SUDC) is a leading category of death for toddlers, but a new report indicates that we may be underestimating the incidence of SUDC.

School readiness has long been touted as a way to ensure the best educational outcomes, but a new study indicates that it can also help with health outcomes too.

A look at what to expect from Contemporary Pediatrics this week

It was a very busy week for the Contemporary Pediatrics team.

Recent guidelines recommend using commercially available plasmalike isotonic fluid therapy, but could this have a negative impact on acutely ill children.

Sklice (ivermectin) lotion, 0.5% has been approved for over-the-counter (OTC) use by the US Food and Drug Administration (FDA) in children aged 6 months and older.

A look at what to expect from Contemporary Pediatrics this week.

It was a very busy week for the Contemporary Pediatrics team.

An investigation examines how governmental spending, in both health and nonhealth areas, can impact infant mortality rates.

A look at what to expect from Contemporary Pediatrics this week

It was a very busy week for the Contemporary Pediatrics team.

Contemporary Pediatrics sat down with Andrew Schuman, MD, FAAP, to discuss the effectively use of technology in pediatrics.